Mass spectrometry in drug discovery and development

被引：3

|

作者：

Michnowicz, J ^{[1
]}

机构：

[1] Agilent Technol, Life Sci & Chem Anal, Palo Alto, CA 94304 USA

来源：

NATURE REVIEWS DRUG DISCOVERY | 2002年 / 1卷 / 08期

关键词：

D O I：

10.1038/nrd886

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Broadly trained scientists with mass spectrometry technical skills add great value to drug discovery teams.

引用

下载

收藏

页码：651 / 651

页数：1

相关论文

共 50 条

[1] Mass spectrometry in drug discovery and development
John Michnowicz
Nature Reviews Drug Discovery, 2002, 1 : 651 - 651
[2] Imaging mass spectrometry in drug discovery and development
Oppenheimer, Stacey R.
Wehr, Angela Y.
BIOANALYSIS, 2015, 7 (20) : 2609 - 2610
[3] Mass Spectrometry Innovations in Drug Discovery and Development
Damon I Papac
Zahra Shahrokh
Pharmaceutical Research, 2001, 18 : 131 - 145
[4] Mass spectrometry imaging in drug discovery and development
Goodwin, Richard
TOXICOLOGY LETTERS, 2016, 258 : S42 - S42
[5] Mass spectrometry innovations in drug discovery and development
Papac, DI
Shahrokh, Z
PHARMACEUTICAL RESEARCH, 2001, 18 (02) : 131 - 145
[6] The Role of Mass Spectrometry in Biopharmaceutical Drug Discovery and Development
Edwards, Ian John
SPECTROSCOPY, 2018, 33 (04) : 36 - 40
[7] Mass spectrometry in drug discovery
Károly Vékey
Reaction Kinetics and Catalysis Letters, 2002, 77 (2): : 397 - 398
[8] Liquid chromatography–mass spectrometry in peptide drug discovery and development
Harald John
Analytical and Bioanalytical Chemistry, 2005, 381 : 51 - 53
[9] Mass Spectrometry in Covalent Drug Discovery
Liu, Chang
Wen, Xiujuan
CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
[10] Editorial: Mass spectrometry-based proteomics in drug discovery and development
Pejchinovski, Martin
Magalhaes, Pedro
Metzger, Jochen
FRONTIERS IN MEDICINE, 2024, 11

← 1 2 3 4 5 →